Chinese antibody cocktail a potential game changer in fight against Covid-19 | South China Morning Post

An antibody treatment for Covid-19 that reportedly cuts hospitalisations and deaths by 78 per cent in clinical trials is expected to be approved for use in China within weeks. Chinese viral immunologist Zhang Linqi is the driving force behind the antiviral cocktail which was put together in about two months. But in …

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.